3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5024
Carcinoma, Renal Cell
1577
Urinary Bladder Neoplasms
1279
Kidney Neoplasms
724
Breast Neoplasms
643
Neoplasms
630
Carcinoma, Transitional Cell
488
Carcinoma, Non-Small-Cell Lung
469
Neoplasm Metastasis
468
Melanoma
421
Ovarian Neoplasms
401
Colorectal Neoplasms
373
Lung Neoplasms
333
Pancreatic Neoplasms
262
Sarcoma
232
Stomach Neoplasms
227
Uterine Cervical Neoplasms
225
Testicular Neoplasms
216
Non-Muscle Invasive Bladder Neoplasms
215
Head and Neck Neoplasms
192
Squamous Cell Carcinoma of Head and Neck
189
Colonic Neoplasms
167
Carcinoma, Hepatocellular
167
Esophageal Neoplasms
165
Endometrial Neoplasms
165
Wilms Tumor
159
Recurrence
131
Triple Negative Breast Neoplasms
130
Small Cell Lung Carcinoma
127
Neuroblastoma
127
Interventions
padeliporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Transitional Cell Cancer of Renal Pelvis and Ureter
×
Genitourinary
×
Clear all
NCT04620239
2026-02-04
UCM301
Steba Biotech S.A.
Phase 3
Recruiting
100 enrolled